Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-30

Clinical Trial Update: Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing continuous intravenous lidocaine infusion to placebo for rib fracture analgesia; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Stanford University | Conditions: Rib Fractures | Phase 4 | Status: TERMINATED | Results posted: 2023-11-30